AI-Powered Performance Intelligence For High-Stakes Enterprise Operations
QI Path’s Performance Intelligence works across high-stakes enterprise environments to anticipate risk, prevent failure, and turn operational data into faster insights that can lead to safer decisions.
QI Path’s AI models and algorithms train on your organization’s protected data to generate enterprise-specific insight. This provides continuous, customizable application of the AI-Human collaboration to improve how your organization learns, operates and performs.
Whether in life sciences, healthcare, or government health programs, QI Path is the enterprise-grade platform to create one standard of continuous learning, data governance, and operational performance.
AI-Powered Performance Intelligence For High-Stakes Enterprise Operations
QI Path’s Performance Intelligence works across high-stakes enterprise environments to anticipate risk, prevent failure, and turn operational data into faster insights that can lead to safer decisions.
QI Path’s AI models and algorithms train on your organization’s protected data to generate enterprise-specific insight. This provides continuous, customizable application of the AI-Human collaboration to improve how your organization learns, operates and performs.
Whether in life sciences, healthcare, or government health programs, QI Path is the enterprise-grade platform to create one standard of continuous learning, data governance, and operational performance.
QI Path’s Patient Registries Turn Data Into Decisions, Not Paperwork
Healthcare systems, hospitals, and government health programs face pressure to modernize fragmented legacy registries and EHR data into a structured “One Source of Truth” for better care decisions.
Built and Proven in the Most Demanding Clinical Environments
Developed for the complex high-risk environment of combat trauma care, QI Path’s Patient Registries Solution can transform scattered patient and operational data in fragmented workflows to a single, integrated environment where patient data can be abstracted, validated, standardized, analyzed – all reported within one secure system.
Integrated within an organization’s specific business rules, QI Path allows users to modify workflows, displays, and views to match how your teams already work, without the cost or delay of traditional software customization.
The Registry also enables standardized analysis across theaters, medical treatment facilities, injury patterns, patient populations, and clinical outcomes. AI-powered customizable dashboards and analytics provide clinicians, researchers, performance improvement teams, and military leaders with near real-time visibility into trends, performance, and emerging risks.
Spend Time Improving Outcomes, Not Chasing Data
QI Path is designed to meet the compliance, security, and operational demands of the most rigorous health environments, where the stakes, and the standards, must be the highest.
Life Sciences Risk Management: Search Out, Prevent Failures Before They Find You
Advanced biologics and other novel modalities brought new layers of operational complexity — globalized manufacturing, sensitive supply chains, decentralized trials, and expanding data streams. Regulators responded with tighter expectations and more proactive oversight.
Built for Risk, Compliance, Speed, and Scale
QI Path’s AI-powered risk intelligence can identify hidden vulnerabilities, accelerate decision-making, and reduce quality and safety issues before they escalate. What used to take months of manual analysis can now take minutes without sacrificing regulatory rigor.
The solution integrates cross-functional risk data from Quality, Clinical, Regulatory, and Manufacturing teams to provide a unified view of exposure. This ensures that risks, deviations, change controls, and CAPAs are treated not as isolated incidents, but as part of an automated, dynamic, and traceable risk ecosystem.
Proactive Risk Analysis
Where traditional quality systems are reactive, QI Path is proactive by mapping systemic vulnerabilities, surfacing unresolved issues before audits, and continuously updating multi-dimensional risk analysis based on real-world data. The result is a smarter, faster, and more resilient quality function built to lead organizations into a new era of operational excellence where vulnerabilities and risks are proactively identified and prevented before they are realized.
Complete Regulatory Alignment
QI Path also aligns with ICH E6(R2/R3), Q9, and QbD for risk management, and 21 CFR Part 11 for electronic records. This can provide pharma, CROs, and drug manufacturers oversight and regulatory readiness across GxP processes, clinical trials, and manufacturing operations.
The Way Forward
QI Path is transforming how the life sciences industry views and manages operational risk. This can help organizations to protect patients and products and also unlock greater speed, efficiency, and confidence in bringing therapies to market.
